OrthoPediatrics (KIDS) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- -$0.23
- Estimate
- -$0.21
- Surprise
- -7.0%
- Revenue (period 2026-09-30)
- $72.7M
- Score at report (before → after)
- 5.6 → 5.4/10
Revenue source: xbrl.
How the report landed
OrthoPediatrics (KIDS) reported a wider loss than forecast — adjusted EPS of -$0.23 against the -$0.21 estimate (a 7.0% shortfall). TrendMatrix's engine moved from Sell (5.6/10) to Hold at 5.4/10 after the report.
Coverage in the report window
- Analysts Update Price Targets for OrthoPediatrics Following Q3 Earnings — fiscal.ai, 2026-10-29
- Multiple Analysts Raise Price Targets on OrthoPediatrics Following Q3 Earnings — fiscal.ai, 2026-10-29
- Lake Street Maintains Buy on OrthoPediatrics, Raises Price Target to $38 — benzinga, 2026-10-28
Where TrendMatrix's rating stands now
TrendMatrix currently rates KIDS Sell at 5.2/10.
3 of the last 4 quarters beat the estimate; this quarter's -7.0% surprise compares with a +3.7% four-quarter average. Next scheduled report: 2027-02-25.
What supports the rating
- Strong earnings beat streak (3/4)
- Strong growth profile
What argues against it
- Analyst target reached - limited upside remaining
- Negative momentum
- Value-trap signals (2/5): Margin compression (op margin -8.1%), Material insider selling (21 sells, 5.68% of cap)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $31.39
- Stop
- $29.20
Model outputs from TrendMatrix’s engine as of 2026-11-17 — shown for context, not personalized investment advice.
KIDS at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $822.5M
- P/E (fwd)
- -41.8
- 52-week range
- $14.42–$34.53
- Off 52-week high
- 9.1%
- RSI (14)
- 53
- Volume vs avg
- 0.21×
- Score today
- 5.2/10